Why I Bought ENVX Ahead of Q2 Earnings

Not financial advice. I bought 3,000 shares of ENVX today at a $4.94 average, ahead of Q2 earnings. For me, this is mainly a qualification and manufacturing de-risking trade. The smartphone program has already cleared 72 of 75 OEM requirements, with two cycle-life tests and one low-temperature power spec remaining. The lead OEM moved to a silicon-specific qualification framework, and the 0.2C customer test was already more than halfway complete in Q1. I went through Chinese and Korean sources, as well as Enovix’s LinkedIn hiring. In Penang, they are hiring around high-volume ramp, yield stabilization, SPC/Cpk and throughput. In China, they are building a sales team around design wins, qualification and volume ramps with Honor, Xiaomi, OPPO, vivo and Lenovo. Steve Bakos, who previously ran the Apple account at Infineon, now leads worldwide sales. Michael Vyvoda, with Apple AirPods NPI and Asian high-volume manufacturing experience, is now COO. The company also already generates real revenue. Through the Routejade acquisition, Enovix gained operating battery manufacturing and a defense business in South Korea. In 2025, one Korean defense subcontractor accounted for roughly 64% of annual revenue. Its cells are used in drone, subsea and munitions applications, while the Korean sales pipeline is now above $130M. Tonight I’m focused on qualification status, cycle-life data, Fab2 yield and dicing throughput. If those show measurable progress, I think the market is pricing in too high a probability of failure.